Continuation Study of Azacitidine with or without Glasdegib in Patients With Untreated Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
A Multi-Center Continuation Study Evaluating Azacitidine With or Without Glasdegib (PF-04449913) in Patients With Previously Untreated Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Category & Conditions: Cancer
Medicine: DAURISMO TABLETS(GLASDEGIB)
ClinicalTrials.gov Identifier (NCT): NCT04842604
Protocol ID: B1371019 Open Label Extension
PrintDownloadOpen Plain Language Summary Result: Click here